《中医药干预衰老专家共识》发布，以岭药业抗衰老业务加速发展

Group 1 - The Fourth International Traditional Chinese Medicine Anti-Aging Conference was successfully held in Wuzhen, Zhejiang, gathering global experts to discuss advancements in anti-aging research and future prospects [1][3] - The release of the "Expert Consensus on Traditional Chinese Medicine Intervention in Aging" marks a significant step in establishing evidence-based practices for anti-aging treatments, particularly highlighting the role of Ba Zi Bu Shen capsules [3][8] Group 2 - Research indicates that aging can be treated as a disease, with 31.4% of 293 diseases identified as age-related, including major conditions like heart disease, stroke, and diabetes, which account for approximately 50% of mortality rates [4] - The Ba Zi Bu Shen capsule has shown effectiveness in improving aging symptoms, enhancing quality of life, and increasing physical capabilities in elderly populations through clinical studies conducted by multiple centers [5][6] Group 3 - Ba Zi Bu Shen capsules have become a significant product for Yiling Pharmaceutical, with sales showing a notable increase compared to the previous year, supported by effective marketing strategies and partnerships with retail pharmacies [6][8] - The aging population in China is projected to exceed 300 million by the end of 2024, representing 22% of the total population, indicating a vast market potential for anti-aging products [8]